Publications - IR Sant Pau

Search

01/10/2025 Efficacy of transcatheter edge-to-edge repair for cardiac implantable electronic device-associated tricuspid regurgitation: insights from the TRI-SPA registry

Ruberti, A, Cepas-Guillén, P, Echarte-Morales, J, Arzamendi, D, Moñivas, V, Carrasco-Chinchilla, F, Pan, MN, Nombela-Franco, L, Pascual, I, Guerreiro, CE, Benito-González, T, Pérez, R, Gomez-Blázquez, I, Amat-Santos, IJ, Flores-Umanzor, E, Cruz-González, I, Sánchez-Recalde, A, Alvarez, ABC, Barreiro-Pérez, M, Sanchis, L, Li, CH, Caneiro-Queija, B, del Trigo, M, Martínez-Carmona, JD, Mesa, D, Quevedo, PJ, Avanzas, P, Estévez-Loureiro, R, Freixaa, X. Efficacy of transcatheter edge-to-edge repair for cardiac implantable electronic device-associated tricuspid regurgitation: insights from the TRI-SPA registry. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(10)DOI:10.1016/j.rec.2025.01.010. PMID:39894161. IF:4.900(Q1/2D).

01/10/2025 Prospective validation of a prespecified algorithm for the management of conduction disturbances after transcatheter aortic valve replacement: The PROMOTE study

Rodés-Cabau, J, Nombela-Franco, L, Muntané-Carol, G, Veiga, G, Regueiro, A, Nazif, T, Serra, V, Asmarats, L, Ribeiro, HB, Latib, A, Poulin, A, Cheema, AN, Jiménez-Quevedo, P, Gomez-Hospital, JA, Ongay, AG, Gabani, R, Arzamendi, D, Brener, M, Calabuig, A, Scotti, A, Gelain, MAS, Labinaz, M, Cepas-Guillén, P, Nuche, J, Cote, M, Del Portillo, JH, Philippon, F. Prospective validation of a prespecified algorithm for the management of conduction disturbances after transcatheter aortic valve replacement: The PROMOTE study. HEART RHYTHM. 2025; 22(10)DOI:10.1016/j.hrthm.2024.12.019. PMID:39694306. IF:5.700(Q1/2D).

01/10/2025 Dissecting ST-Segment Elevation Myocardial Infarction Pathophysiology Through Invasive Physiology: Prognostic Insight or Actionable Clinical Guidance?

Jamhour-Chelh, K, Jimenez-Kockar, M, Fernandez-Peregrina, E, Arzamendi, D. Dissecting ST-Segment Elevation Myocardial Infarction Pathophysiology Through Invasive Physiology: Prognostic Insight or Actionable Clinical Guidance?. CANADIAN JOURNAL OF CARDIOLOGY. 2025; 41(10)DOI:10.1016/j.cjca.2025.07.015. PMID:40680880. IF:5.300(Q1/2D).

01/10/2025 Consensus on the Management of the Clinical Challenges of Venous Thromboembolism in Special Situations

Marzo, C, Solanich, T, Tassies, D, Pina, E, Rebollo, MA, Gallardo, E, Serradell, S, Merino, M, Carrasco, M, Tugues, A. Consensus on the Management of the Clinical Challenges of Venous Thromboembolism in Special Situations. THROMBOSIS AND HAEMOSTASIS. 2025; 125(10)DOI:10.1055/a-2595-1811. PMID:40359988. IF:4.300(Q1/2D).

01/10/2025 Monocyte/Macrophages: Unexpected Allies in the Fight Against Arterial Thrombosis?

Vilahur, G, Borrell-Pagés, M. Monocyte/Macrophages: Unexpected Allies in the Fight Against Arterial Thrombosis?. THROMBOSIS AND HAEMOSTASIS. 2025; 125(10)DOI:10.1055/a-2641-6568. PMID:40614767. IF:4.300(Q1/2D).

01/10/2025 Immunometabolism in heart failure

Andreadou, I, Ghigo, A, Nikolaou, PE, Swirski, FK, Thackeray, JT, Heusch, G, Vilahur, G. Immunometabolism in heart failure. Nature Reviews Cardiology. 2025; 22(10)DOI:10.1038/s41569-025-01165-8. PMID:40544171. IF:44.200(Q1/1D).

01/10/2025 Reduced Growth and Inflammation in Lrp5-/- Mice Adipose Tissue

Luquero, A, Pimentel, N, Vilahur, G, Badimon, L, Borrell-Pages, M. Reduced Growth and Inflammation in Lrp5-/- Mice Adipose Tissue. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2025; 29(19)DOI:10.1111/jcmm.70670. PMID:41078090. IF:4.200(Q2/3D).

01/10/2025 The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia (vol581, 112113, 2024)

Ma, CX, Ma, XN, Liu, JJ, Guan, CH, Li, YD, Zhao, N, Mauricio, D, Fu, SB. The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia (vol581, 112113, 2024). MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2025; 608DOI:10.1016/j.mce.2025.112626. PMID:40750504. IF:3.600(Q2/4D).

01/10/2025 Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve Glycemic Control and Quality of Life Compared with a Hybrid System in Patients with Type 1 Diabetes? A Descriptive Open-Label Sequential Study

Alarcón, PP, Alvarez, ED, Goitia, CL, Rodríguez, MM, Urbon, L, Maldonado, A, García, S, Serrallonga, NB, Aviño, LR, Palomar, JMR, Lopez, JG, Hoyas, CIN, Corcoy, R, Raimond, TM, López, ML, Madorell, BS, Hernández, M, Kyriakos, G, Bellas, LC, Borrás, JG, Servant, OS, Colet, AM, Serrano, C, Contreras, C, Román, AR, Díez, M, Veladesojo, A, Andujar, P, Diez, A, Galiana, PA, Peris, BP, Fernandez, E, Ferrer, M, Alfonso, FJG, Torre, ELM. Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve Glycemic Control and Quality of Life Compared with a Hybrid System in Patients with Type 1 Diabetes? A Descriptive Open-Label Sequential Study. Diabetes Technology & Therapeutics. 2025; 27(10)DOI:10.1177/15209156251363452. PMID:40729095. IF:6.300(Q1/2D).

01/10/2025 A global survey of diagnostic practices in prosthetic joint infections

Subedi, S, Harris, PN, Chapman, P, Chen, AF, Davis, JS, Liu, PY, Marais, LC, Salles, MJ, Roberts, JA, Rodriguez-Bano, J, Wouthuyzen-Bakker, M, Paterson, DL, Benito, N. A global survey of diagnostic practices in prosthetic joint infections. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2025; 113(2)DOI:10.1016/j.diagmicrobio.2025.116919. PMID:40480080. IF:1.800(Q3/7D).

01/10/2025 Eltrombopag for Bone Marrow Failure in Fanconi Anemia: Results From the Phase II Clinical Trial FANCREV

Iriondo, J, Zubicaray, J, Rio, P, Catala, A, Solsona, M, Sanz, A, Gomez, A, Sebastian, E, de la Cruz, A, Galan, A, Navarro, S, Larcher, L, de Andoin, NG, Uriz, JJ, Vagace, JM, de Pablo, JG, Pujol, MR, Nicoletti, E, Surralles, J, Martin-Prado, S, Schwartz, JD, Soulier, J, Bueren, JA, Sevilla, J. Eltrombopag for Bone Marrow Failure in Fanconi Anemia: Results From the Phase II Clinical Trial FANCREV. EUROPEAN JOURNAL OF HAEMATOLOGY. 2025; 115(4)DOI:10.1111/ejh.70007. PMID:40665878. IF:2.300(Q2/5D).

01/10/2025 Oncological needs in transgender patients

de la Peña, FA, Martínez-Ramos, D, Juan-Vidal, O, Gómez-Balaguer, M, Miguélez, M, Páez, D, Arrazubi, V, González, CH. Oncological needs in transgender patients. Clinical & Translational Oncology. 2025; 27(10)DOI:10.1007/s12094-025-03917-x. PMID:40251439. IF:2.500(Q3/6D).

01/10/2025 Effectiveness and Safety of Cabozantinib Treatment in Patients with Advanced Renal Cell Carcinoma in Spanish and Portuguese Real-world Practice: The SOGUG-SPRWEC Study

Suárez, C, Torras, OR, Barrera, RM, Sánchez, AR, Palacios, GA, Manshino, AMB, Núñez, NF, Vidal, MJM, Carbonero, IG, Calvo, OF, Sarrió, RG, Herrero, GC, Afonso, JA, Fita, MJJ, Padró, JG, Quintela, ML, Rodriguez-Vida, A, Perez, CH, Colmenero, AM, Martin, RC, de España, CG, Palau, CM, Ortega, EM, Gallardo, E. Effectiveness and Safety of Cabozantinib Treatment in Patients with Advanced Renal Cell Carcinoma in Spanish and Portuguese Real-world Practice: The SOGUG-SPRWEC Study. Clinical Genitourinary Cancer. 2025; 23(5)DOI:10.1016/j.clgc.2025.102402. PMID:40830022. IF:2.700(Q2/3D).

01/10/2025 Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials

Palmerini, E, Meazza, C, Tamburini, A, Márquez-Vega, C, Bisogno, G, Fagioli, F, Ferraresi, V, Milano, GM, Coccoli, L, Rubio-San-Simón, A, Gallego, O, Riestra, MEL, Manzitti, C, Mora, J, Vaz-Salgado, MA, Luksch, R, Mata, C, Pierini, M, Carretta, E, Cesari, M, Paioli, A, Marrari, A, Scotlandi, K, Serra, M, Asaftei, SD, Gambarotti, M, Picci, P, Ferrari, S, Valverde, C, Ibrahim, T, Broto, JM. Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials. JOURNAL OF CLINICAL ONCOLOGY. 2025; 43(28)DOI:10.1200/JCO-25-00210. PMID:40825172. IF:41.900(Q1/1D).

01/10/2025 Assessing outcomes emerging after conversion to regular approval for cancer drug indications granted accelerated approval, 1992-2021

Tibau, A, Romano, A, Liu, ITT, Han, J, Cliff, ERS, Kesselheim, AS. Assessing outcomes emerging after conversion to regular approval for cancer drug indications granted accelerated approval, 1992-2021. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2025; 117(10)DOI:10.1093/jnci/djaf195. PMID:40690366. IF:7.200(Q1/2D).

01/10/2025 Exploring communication preferences for disclosing breast cancer risk in women with a family history

López-Fernández, A, Pardo, M, Pérez-Ballestero, E, Darder, E, Alfonso, R, Torres-Esquius, S, Garcés, VN, Cajal, TRY, Brunet, J, Balmaña, J. Exploring communication preferences for disclosing breast cancer risk in women with a family history. Journal of Genetic Counseling. 2025; 34(5)DOI:10.1002/jgc4.70114. PMID:40965181. IF:1.900(Q2/5D).

01/10/2025 Metastatic melanoma mimicking an angiomatoid fibrous histiocytoma

Fumagalli, C, Mozos, A, Szafranska, J, Orellana, R. Metastatic melanoma mimicking an angiomatoid fibrous histiocytoma. Revista Espanola De Patologia. 2025; 58(4)DOI:10.1016/j.patol.2025.100841. PMID:40902304. IF:(Q/D).

01/10/2025 Neuropilin-2 upregulation by stromal TGFß1 induces lung disseminated tumor cells dormancy escape and promotes metastasis outgrowth

Recalde-Percaz, L, de la Guia-lopez,, Linzoain-Agos, P, Noguera-Castells, A, Rodrigo-Faus, M, Jauregui, P, Lopez-Plana, A, Fernández-Nogueira, P, Iniesta-González, M, Cueto-Remacha, M, Manzano, S, Alonso, R, Moragas, N, Baquero, C, Palao, N, Dalla, F, Avilés-Jurado, FX, Vilaseca,, León-Vintró, X, Camacho, M, Fuster, G, Alcaraz, J, Aguirre-Ghiso, J, Gascón, P, Porras, A, Gutiérrez-Uzquiza, A, Carbó, N, Bragado, P. Neuropilin-2 upregulation by stromal TGFß1 induces lung disseminated tumor cells dormancy escape and promotes metastasis outgrowth. NEOPLASIA. 2025; 68DOI:10.1016/j.neo.2025.101220. PMID:40848614. IF:7.700(Q1/2D).

01/10/2025 Evaluation of Clinical Outcomes and Treatment Complications in Hairy Cell Leukemia: A Single-Center Retrospective Analysis

Fasanella, MG, Mozos, A, Briones, J, Nomdedeu, JF, Novelli, S. Evaluation of Clinical Outcomes and Treatment Complications in Hairy Cell Leukemia: A Single-Center Retrospective Analysis. Cancer Reports. 2025; 8(10)DOI:10.1002/cnr2.70356. PMID:41031578. IF:(Q/D).

01/10/2025 Clinical-assistance and medical-legal aspects of the use of electric weapons.

Puig Campmany M, Martin-Fumadó C, Pujol-Robinat A, Arimany-Manso J. Clinical-assistance and medical-legal aspects of the use of electric weapons.. MEDICINA CLINICA. 2025; 165(4)DOI:10.1016/j.medcli.2025.107121. PMID:40680410. IF:(Q/D).

01/10/2025 International recommendations for sleep and circadian research in aging and Alzheimer's disease: A Delphi consensus study.

André C, Stankeviciute L, Michaelian JC, Antonsdottir IM, Benca RM, Coulthard EJ, D'Rozario AL, Dijk DJ, Gimenez S, Gorgoni M, Leng Y, Lucey BP, Pase MP, Rainey-Smith SR, Rosenzweig I, Spira AP, Winer JR, Rauchs G, Naismith SL. International recommendations for sleep and circadian research in aging and Alzheimer's disease: A Delphi consensus study.. ALZHEIMERS & DEMENTIA. 2025; 21(10)DOI:10.1002/alz.70742. PMID:41164883. IF:(Q/D).

01/10/2025 Impact on safety and cost of pharmaceutical interventions in the emergency department (INTERPHAR): a standardized methodology for multicenter documentation

Ramos-Rodríguez, J, Bonete-Sánchez, M, Ruiz-Ramos, J, Calderon-Hernanz, B, Campino-Villegas, A, de Lorenzo-Pinto, A, García-Peláez, M, García-Gutiérrez, MD, García-Martin, A, Real-Campaña, JM, Ginés-Palomares, A, Such-Díaz, A, Vallvé-Alcon, E, Alonso-Ramos, H. Impact on safety and cost of pharmaceutical interventions in the emergency department (INTERPHAR): a standardized methodology for multicenter documentation. EMERGENCIAS. 2025; 37(5)DOI:10.55633/s3me/082.2025. PMID:41185476. IF:6.300(Q1/1D).

01/10/2025 Telematic intervention on frailty in patients undergoing TAVI. Design of the TELE-FRAIL TAVI clinical trial

Bernal-Labrador, E, Romaguera, R, Garcia-Blas, S, Regueiro, A, Serra, V, Asmarats, L, Tizon-Marcos, H, Agudelo, V, Scardino, C, Casanova-Sandoval, JM, Rodríguez-Gabella, T, Jiménez-Méndez, C, Pérez-Rivera, A, Robles-Gamboa, C, Ayesta, A, Díez-Villanueva, P, Raposeiras-Roubín, S, Amat-Santos, IJ, Esteve-Pastor, A, Veiga-Fernández, G, Anguita, M, Martí-Sánchez, D, Martínez-Velilla, N, Cortés, L, Calvo, E, Asimbaya, S, Formiga, F, Ariza-Solé, A. Telematic intervention on frailty in patients undergoing TAVI. Design of the TELE-FRAIL TAVI clinical trial. REC, interventional cardiology. 2025; 7(4)DOI:10.24875/RECIC.M25000522. PMID:41333125. IF:(Q/D).

01/10/2025 Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis

Romero-Gómez, M, Escalada, J, Noguerol, M, Pérez, A, Carretero, J, Crespo, J, Mascort, JJ, Aguilar, I, Tinahones, F, Canones, P, Gómez-Huelgas, R, de Luis, D, Trullos, IG, Aller, R, Rubio, MA. Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis. Gastroenterologia y Hepatologia. 2025; 48(8)DOI:10.1016/j.gastrohep.2025.502442. PMID:40221023. IF:1.900(Q3/7D).

01/10/2025 Endocrine-disrupting chemicals exposure: cardiometabolic health risk in humans

Ma, CX, Ma, XN, Li, HL, Mauricio, D, Fu, SB. Endocrine-disrupting chemicals exposure: cardiometabolic health risk in humans. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02938-8. PMID:41035032. IF:10.600(Q1/1D).

01/10/2025 Leveraging AI for early detection of chronic kidney and hereditary kidney diseases: a focus on Alport syndrome

Ramírez, ERV, de Maeztu, G, de Arizón, LF, Teran, MP, Torra, R. Leveraging AI for early detection of chronic kidney and hereditary kidney diseases: a focus on Alport syndrome. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40DOI:10.1093/ndt/gfaf116.1061. PMID:. IF:5.600(Q1/1D).

01/10/2025 High effectiveness and rare virologic failure in treatment-experienced individuals on long-acting cabotegravir plus rilpivirine therapy across Europe: Insights from the EuroSIDA study

Peters, L, Bannister, W, Sridhar, G, Gardizi, M, van Frankenhuijsen, M, De Scheerder, MA, Johansen, IS, Viard, JP, Duvivier, C, Bogner, J, Degen, O, Castagna, A, Staub, T, Martinez, E, Domingo, P, Moreno, S, Reikvam, DH, Parczewski, M, Knysz, B, Shivkar, Y, Brown, K, van Wyk, J, Vannappagari, V. High effectiveness and rare virologic failure in treatment-experienced individuals on long-acting cabotegravir plus rilpivirine therapy across Europe: Insights from the EuroSIDA study. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

01/10/2025 CD163+macrophages: a prognostic marker in ANCA vasculitis?

Benito-García, S, Bardaji, B, Arce, Y, Moya, P, Freiria, XB, Marco, H, Perich, LG, Encarnacion, MMD. CD163+macrophages: a prognostic marker in ANCA vasculitis?. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40DOI:10.1093/ndt/gfaf116.0218. PMID:. IF:5.600(Q1/1D).

01/10/2025 ARIAN, Adjuvant Treatment With Sacituzumab and ZimberelimAb in Resected Patients: A Phase III Study-Trial in Progress

Provencio, M, Aguiar, D, Antoñanzas, M, Areses, MC, Azkárate, A, Barba, A, Bernabé, R, Blanco, R, Borregon, M, Campos, B, Coves, J, De Castro, J, Domènech, M, Domine, M, Campelo, RG, Gozálvez, CL, Huidobro, G, Insa, A, Juan-Vidal, O, Castro, RL, Martínez-Marti, A, Medina, S, Moreno, MA, Nadal, E, Olivares, A, Reguart, N, Sala, MA, Medina, K, Vilà, L, Massuti, B. ARIAN, Adjuvant Treatment With Sacituzumab and ZimberelimAb in Resected Patients: A Phase III Study-Trial in Progress. Journal of Thoracic Oncology. 2025; 20(10)DOI:. PMID:. IF:20.800(Q1/1D).

01/10/2025 Early Treatment Discontinuation of Osimertinib in the Adjuvant Setting: Insights From the ADAURA Study

Grohé, C, Wu, YL, Tsuboi, M, Majem, M, John, T, Bolanos, A, Taylor, R, Sandelin, M, Herbst, RS. Early Treatment Discontinuation of Osimertinib in the Adjuvant Setting: Insights From the ADAURA Study. Journal of Thoracic Oncology. 2025; 20(10)DOI:. PMID:. IF:20.800(Q1/1D).

01/10/2025 From fibro/adipogenic progenitors to adipocytes: Understanding adipogenesis in muscle degeneration for disease modulation

Villalobos, E, Mehra, P, Diaz-Manera, J. From fibro/adipogenic progenitors to adipocytes: Understanding adipogenesis in muscle degeneration for disease modulation. JOURNAL OF PHYSIOLOGY-LONDON. 2025; 603(19)DOI:10.1113/JP288924. PMID:40846464. IF:4.400(Q1/1D).

01/10/2025 INTERACTION OF PREVIOUS MAJOR ADVERSE CARDIOVASCULAR EVENTS, ANTITHROMBOTICS, AND STATINS ON OUTCOMES IN INTRACEREBRAL HEMORRHAGE

Prats-Sanchez, L, Lambea-Gil, A, Martí-Fàbregas, J, Ezcurra, G, Guasch, M, Fernandez-Vidal, JM, Renom, PC, Martínez-Domeño, A, Ramos-Pachón, A, Hic-Cat, I. INTERACTION OF PREVIOUS MAJOR ADVERSE CARDIOVASCULAR EVENTS, ANTITHROMBOTICS, AND STATINS ON OUTCOMES IN INTRACEREBRAL HEMORRHAGE. International Journal of Stroke. 2025; 20DOI:. PMID:. IF:8.700(Q1/1D).

01/10/2025 Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study

Tolosa-Ridao, C, González, MB, Gómez, MA, Fox, L, Artigas, MDP, Santamaria, A, González, MDQ, Salinas, AS, Camacho, JMS, Alvaro, VI, Abdallahi-Lefdil, Z, Navascues, JC, Pardo, L, Fernández-Luis, S, Suárez, LPV, Villar, S, Beorlegui-Murillo, P, Esquirol, A, García, II, Ribes-Amorós, J, Lavilla, E, Lopez-Marín, J, Basalobre, P, Filaferro, S, Cedillo, A, Bento, L, Sureda, A, Salas, MQ. Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study. BRITISH JOURNAL OF HAEMATOLOGY. 2025; 207(4)DOI:10.1111/bjh.70068. PMID:40796522. IF:3.800(Q1/3D).

01/10/2025 The Barcelona injury surveillance system

Pérez, K, Santamariña-Rubio, E, Cortés-Albadalejo, M, Artazcoz, L, Hyder, AA, Kass, D, Borrell, C. The Barcelona injury surveillance system. EUROPEAN JOURNAL OF PUBLIC HEALTH. 2025; 35DOI:10.1093/eurpub/ckaf161.884. PMID:. IF:3.900(Q1/2D).

01/10/2025 Safety and efficacy of SGLT2i in non-diabetic kidney transplant recipients

Robles, CA, Quilis, A, Gómez, PF, López, V, Vigara, LA, Borrás, PGC, Torres-Sánchez, MJ, Canal, C, del Valle, AISS, Cuellar, HT, Fructuoso, AIS, Buxeda, A. Safety and efficacy of SGLT2i in non-diabetic kidney transplant recipients. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40DOI:10.1093/ndt/gfaf116.0884. PMID:. IF:5.600(Q1/1D).

01/10/2025 Effect of female sex hormones on liver volume: assessing the safety of preimplantation genetic diagnosis in women with ADPKD

Aranda, APT, Toso, D, Polo, A, Martínez, O, Ramírez, ERV, Hernández, J, Ars, E, Torra, R, Furlano, M. Effect of female sex hormones on liver volume: assessing the safety of preimplantation genetic diagnosis in women with ADPKD. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40DOI:10.1093/ndt/gfaf116.0191. PMID:. IF:5.600(Q1/1D).

01/10/2025 Refining quality control strategies in highly automated laboratories: experience in the integration of multistage statistical designs and risk management

Costa-Pallaruelo, M, García-Osuna, A, Canyelles, M, Martínez-Bru, C, Nan, N, Ferrer-Perez, R, Blanco-Vaca, F, Guiñon, L. Refining quality control strategies in highly automated laboratories: experience in the integration of multistage statistical designs and risk management. Biochemia Medica. 2025; 35(3)DOI:10.11613/BM.2025.030704. PMID:41103687. IF:1.800(Q3/6D).

01/10/2025 Commentary on: Acute retinal necrosis associated with dimethyl fumarate

Vidal-Jordana, A. Commentary on: Acute retinal necrosis associated with dimethyl fumarate. Multiple Sclerosis Journal. 2025; 31(12)DOI:10.1177/13524585251326487. PMID:40320665. IF:5.000(Q1/2D).

01/10/2025 A Systematic Review of Outcomes of Redo Ureteroneocystostomy Subsequent to Kidney Transplantation in Pediatric Recipients

Haberal, HB, Marco, BB, Donmez, MI, Pecoraro, A, Piana, A, Prudhomme, T, López-Abad, A, Breda, A, Territo, A. A Systematic Review of Outcomes of Redo Ureteroneocystostomy Subsequent to Kidney Transplantation in Pediatric Recipients. INTERNATIONAL JOURNAL OF UROLOGY. 2025; 32(10)DOI:10.1111/iju.70148. PMID:40488818. IF:2.200(Q2/5D).

30/09/2025 Candidate Transcript Panel in Semen Extracellular Vesicles Can Improve Prediction of Aggressiveness of Prostate Cancer

Ferre-Giraldo, A, Castells, M, Madurga, A, Arbiol-Roca, A, de Rocco-Ponce, M, Bassas, L, Vigués, F, Larriba, S. Candidate Transcript Panel in Semen Extracellular Vesicles Can Improve Prediction of Aggressiveness of Prostate Cancer. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(19)DOI:10.3390/ijms26199562. PMID:41096831. IF:4.900(Q1/3D).

30/09/2025 Myocardial infarction induces endothelial dysfunction with independence of cardiovascular risk factors

Jimenez-Trinidad, FR, Solanes, N, Arrieta, M, Llonch, B, Roque, M, Freixa, X, Brugaletta, S, Ortega-Paz, L, Rodriguez, JJ, Cepas-Guillen, P, Vilhaur, G, Sabate, M, Dantas, AP, Tura-Ceide, O, Rigol, M. Myocardial infarction induces endothelial dysfunction with independence of cardiovascular risk factors. ANGIOGENESIS. 2025; 28(4)DOI:10.1007/s10456-025-10006-8. PMID:41028611. IF:9.200(Q1/1D).

30/09/2025 Multidisciplinary approach for patients with early and locally advanced non-small cell lung cancer (NSCLC): 2nd Spanish Lung Cancer Group (GECP) expert consensus statement

Ospina-Serrano, AV, González-Larriba, JL, Nadal, E, Trancho, FH, Bosch-Barrera, J, Calvo, V, Bolufer-Nadal, S, de la Cruz, JLCC, Macía-Vidueira, I, Alvarez-Kindelán, A, Del Barco-Morillo, E, Bernabé-Caro, R, Casal-Rubio, J, Cilleruelo-Ramos, A, Cobo-Dols, M, Dómine-Gómez, M, Figueroa-Almánzar, S, Insa-Mollá, A, Jarabo-Sarceda, JR, Jiménez-Maestre, U, López-Castro, R, Majem, M, Martinez-Marti, A, Téllez, EM, Sánchez-Lorente, D, López-Valcárcel, M, Couñago, F, Garcia-Campelo, R, de Castro, J, Massuti-Sureda, B, Provencio, M. Multidisciplinary approach for patients with early and locally advanced non-small cell lung cancer (NSCLC): 2nd Spanish Lung Cancer Group (GECP) expert consensus statement. Translational Lung Cancer Research. 2025; 14(9)DOI:10.21037/tlcr-2025-619. PMID:41132973. IF:3.500(Q1/3D).

30/09/2025 Non-Competitive Binding of Isatuximab and Daratumumab to CD38: Implications for Targeted Therapy in Multiple Myeloma

Osuna-Gómez, R, López-Pardo, J, Mulet, M, Nomdedéu, J, Cantó, E, Ortin, R, Cayuela, AS, Ortiz, MA, Guinart-Cuadra, A, Vidal, S. Non-Competitive Binding of Isatuximab and Daratumumab to CD38: Implications for Targeted Therapy in Multiple Myeloma. Pharmaceutics. 2025; 17(10)DOI:10.3390/pharmaceutics17101278. PMID:41155915. IF:5.500(Q1/1D).

29/09/2025 Emergency Department Reconsultations After a Secondary Prevention Bundle for Medication-Related Problems: A Retrospective Cohort Study

Plaza-Díaz, A, Juanes-Borrego, A, Sanz-Lopez, N, González-Bueno, J, Fernández-Morató, J, García-Peláez, M, Ruiz-Ramos, J. Emergency Department Reconsultations After a Secondary Prevention Bundle for Medication-Related Problems: A Retrospective Cohort Study. Journal of Clinical Medicine. 2025; 14(19)DOI:10.3390/jcm14196907. PMID:41095987. IF:2.900(Q1/2D).

29/09/2025 Effects of Nordic Walking on Physical Fitness in Patients with Cancer: A Systematic Review

Casanovas-Alvarez, A, Mur-Gimeno, E, Ayala, JM, Fernández-Jané, C, Sebio-Garcia, R. Effects of Nordic Walking on Physical Fitness in Patients with Cancer: A Systematic Review. Cancers. 2025; 17(19)DOI:10.3390/cancers17193170. PMID:41097698. IF:4.400(Q2/3D).

29/09/2025 Obesity alters VLDL profile and remnant cholesterol differently in metabolically healthy men and women: a 1H-NMR study

Santisteban, V, López-Yerena, A, Muñoz-Garcia, N, Vilahur, G, Badimon, L, Padro, T. Obesity alters VLDL profile and remnant cholesterol differently in metabolically healthy men and women: a 1H-NMR study. Lipids in Health and Disease. 2025; 24(1)DOI:10.1186/s12944-025-02723-2. PMID:41024030. IF:4.200(Q1/3D).

29/09/2025 Diagnosis and Therapy of Soft Tissue Sarcomas: Spanish Group for Research in Sarcomas (GEIS) Guidelines

Vaz-Salgado, MA, Valverde-Morales, C, Alvarez, R, Asencio, JM, Collado, E, de Alava, E, Beveridge, RD, Gómez-Mateo, MC, Alegria, IG, Marquina, G, Broto, JM, Martínez-Trufero, J, Narváez, JA, Redondo, A, Sebio, A, Verges, R, Viñals, JM, del Muro, XG. Diagnosis and Therapy of Soft Tissue Sarcomas: Spanish Group for Research in Sarcomas (GEIS) Guidelines. Cancers. 2025; 17(19)DOI:10.3390/cancers17193158. PMID:41097686. IF:4.400(Q2/3D).

27/09/2025 Minimally invasive evacuation for spontaneous supratentorial haemorrhage: scoping for candidates and hypothetical logistic burdens in a pragmatic scenario

Mosteiro, A, Coronel-Coronel, M, Pedrosa, L, Lambea-Gil, A, Torne, R, Camps-Renom, P, Prats-Sanchez, L, Marti-Fabregas, J, Amaro, S, Ramos-Pachón, A. Minimally invasive evacuation for spontaneous supratentorial haemorrhage: scoping for candidates and hypothetical logistic burdens in a pragmatic scenario. NEUROSURGICAL REVIEW. 2025; 48(1)DOI:10.1007/s10143-025-03823-4. PMID:41014383. IF:2.500(Q1/3D).

27/09/2025 Icotrokinra in psoriasis: IL-23 receptor antagonism via oral peptide with biologic-level efficacy

Puig, L. Icotrokinra in psoriasis: IL-23 receptor antagonism via oral peptide with biologic-level efficacy. LANCET. 2025; 406(10510)DOI:10.1016/S0140-6736(25)01675-7. PMID:40976247. IF:88.500(Q1/1D).

26/09/2025 Caspase-3 in Brain Death Donors Is Associated with Reduced Primary Graft Dysfunction After Heart Transplantation

Herrador, L, González-Costello, J, Niubo-Bosch, J, Calatayud-Samper, L, Maestro-Benedicto, A, Farrero-Torres, M, Blasco-Peiro, T, Almenar-Bonet, L, Blázquez-Bermejo, Z, Garrido-Bravo, I, Gran-Ipiña, F, Grande-Trillo, A, Manito, N, Moreno-Gonzalez, G. Caspase-3 in Brain Death Donors Is Associated with Reduced Primary Graft Dysfunction After Heart Transplantation. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(19)DOI:10.3390/ijms26199434. PMID:41096699. IF:4.900(Q1/3D).

26/09/2025 Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation

Torrent-Rodríguez, A, Cascos, E, Garcés, VN, Pérez-López, E, Baile-González, M, Rodríguez, CM, Cascón, MJP, Luque, M, Esquirol, A, Calvo, CM, Peña-Muñoz, F, Fernando, IH, Ormtegi, IO, Marín, AJS, Fernández-Luis, S, Domínguez-García, JJ, Fernández, SV, Lorenzo, JLL, Girón, MFD, Pinedo, LG, García-Maño, L, González-Rodriguez, AP, Torrado, T, Filaferro, S, Basalobre, P, Ortí, G, Rovira, M, Chacón, MJ, Salas, MQ. Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation. Cancers. 2025; 17(19)DOI:10.3390/cancers17193128. PMID:41097656. IF:4.400(Q2/3D).

24/09/2025 Which Physical Therapy Intervention Is Most Effective in Reducing Secondary Lymphedema Associated with Breast Cancer? A Systematic Review and Network Meta-Analysis

Aguilera-Eguía, RA, Serón, P, Gutiérrez-Arias, R, Herrera-Serna, B, Pérez-Galdavini, V, Inostroza-Reyes, G, Yáñez-Baeza, C, Fuentes-Barría, H, Arriagada, HB, Inostroza-Quiroz, J, Melo-Lonconao, M, Alarcón-Rivera, M, Muñoz-Bustos, M, Pinzón-Bernal, M, López-Soto, P, Roco-Videla, A, Angarita-Dávila, L, Bonfill, X, Zaror, C. Which Physical Therapy Intervention Is Most Effective in Reducing Secondary Lymphedema Associated with Breast Cancer? A Systematic Review and Network Meta-Analysis. Journal of Clinical Medicine. 2025; 14(19)DOI:10.3390/jcm14196762. PMID:41095841. IF:2.900(Q1/2D).

24/09/2025 Hepatitis A in Spain: Evolution of hospitalization in the period 2000-2021

Dominguez, A, Torner, N, Soldevila, N, Varela, C, Guerrero-Vadillo, M, Peñuelas, M, Avellón, A, Borràs, E, Martinez, A, Plans, P, Pericas, C, Rius, C, Godoy, P. Hepatitis A in Spain: Evolution of hospitalization in the period 2000-2021. PLoS One. 2025; 20(9)DOI:10.1371/journal.pone.0332317. PMID:40991636. IF:2.600(Q2/4D).

22/09/2025 The Predictive Value of Emotion Regulation in Cocaine Use Disorder Severity: Psychotherapeutic Implications During Hospitalization for Detoxification

Palazón-Llecha, A, Trujols, J, Madre, M, Duran-Sindreu, S, Batlle, F, Mallorqui-Bague, N. The Predictive Value of Emotion Regulation in Cocaine Use Disorder Severity: Psychotherapeutic Implications During Hospitalization for Detoxification. CLINICAL PSYCHOLOGY & PSYCHOTHERAPY. 2025; 32(5)DOI:10.1002/cpp.70155. PMID:40983318. IF:2.700(Q2/3D).

22/09/2025 A network meta-analysis of the safety of systemic treatments in patients with metastatic hormone-sensitive prostate cancer

Di Maio, M, Gonzalez-Billalabeitia, E, Marandino, L, Maroto, P, Timsit, MO, Luccarini, I, Robinson, P, Van Sanden, S, Hadaschik, BA. A network meta-analysis of the safety of systemic treatments in patients with metastatic hormone-sensitive prostate cancer. Frontiers in Oncology. 2025; 15DOI:10.3389/fonc.2025.1468928. PMID:41059299. IF:3.300(Q2/4D).

22/09/2025 Prevalence of Fms-Like Tyrosine Kinase 3 (FLT3) Mutations in Patients With Acute Myeloid Leukaemia: A Systematic Literature Review and Meta-Analysis

Lewis, JFM, Daver, NG, Robinson, NJ, Pandya, BJ, Pierre-Louis, B, Monir, S, Sierra, J. Prevalence of Fms-Like Tyrosine Kinase 3 (FLT3) Mutations in Patients With Acute Myeloid Leukaemia: A Systematic Literature Review and Meta-Analysis. Cancer Medicine. 2025; 14(18)DOI:10.1002/cam4.71205. PMID:40981231. IF:3.100(Q2/5D).

19/09/2025 Mitochondrial methylcytosines as blood-based biomarkers for Alzheimer's disease dementia prognosis

Gascón-Bayarri, J, Mosquera, JL, Blanch, M, Marti, P, Fontal, B, Trapero, C, Rojo, N, Rico, I, Campdelacreu, J, Fowler, C, Laws, SM, Tort-Merino, A, Sanchez-Valle, R, Bello, J, Fortea, J, Lleo, A, Mehanian, C, Swerdlow, RH, Reñe-Ramirez, R, Barrachina, M. Mitochondrial methylcytosines as blood-based biomarkers for Alzheimer's disease dementia prognosis. iScience. 2025; 28(9)DOI:10.1016/j.isci.2025.113418. PMID:40978150. IF:4.100(Q1/2D).

19/09/2025 Circulating tumor DNA in patients with cancer: insights from clinical laboratory

Illana, FJ, Fernández-Galán, E, Muñoz-Bravo, JL, Amado, LV, Martín, CG, González-Fernández, C, Miró-Cañís, S, Trapé, J, Martínez-Peinado, A, Filella, X, González, A, Sánchez, AB, Díaz-Lagares, A. Circulating tumor DNA in patients with cancer: insights from clinical laboratory. ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO. 2025; 6(3)DOI:10.1515/almed-2025-0010. PMID:40977813. IF:(Q/D).

19/09/2025 Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study

Puig, R, Rojo-López, MI, Julve, J, Castelblanco, E, Ponomarenko, J, Amezqueta, S, Vendrell, J, Franch-Nadal, J, Torres, JL, Mauricio, D, Ramos-Romero, S. Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study. Nutrients. 2025; 17(18)DOI:10.3390/nu17183003. PMID:41010528. IF:5.000(Q1/2D).

18/09/2025 Histological guided treatment in paediatric patients presenting with severe left ventricular dysfunction

Dolader, P, Corrales, DCJ, Esmel-Vilomara, R, Daina, C, Izquierdo-Blasco, J, Fernandez, E, Garrido-Pontnou, M, Navarro, A, Camacho, J, Fidalgo, A, Sánchez-Salmador, R, Escudero, F, Sorli, M, Betrian-Blasco, P, Roses-Noguer, F, Gran, F. Histological guided treatment in paediatric patients presenting with severe left ventricular dysfunction. EUROPEAN JOURNAL OF PEDIATRICS. 2025; 184(10)DOI:10.1007/s00431-025-06424-x. PMID:40965764. IF:2.600(Q1/2D).